Research News & Publications

Cell-free DNA identifies early signs of relapse in pediatric medulloblastoma

10/21/2021

Findings from St. Jude Children’s Research Hospital show that cell-free DNA in cerebrospinal fluid can be used to detect measurable residual disease and identify patients at risk of relapse.
Biomarker predicts medulloblastoma relapse

10/21/2021

St. Jude scientists developed a test to look for signals that identify the presence of cell-free DNA from medulloblastoma.
Changing tumor cell identity

10/20/2021

Scientists at St. Jude and Dana-Farber Cancer Institute learned how retinoic acid changes tumor cells in children with high-risk neuroblastoma.
Promising preclinical cancer therapy harnesses a newly discovered cell death pathway

10/19/2021

Results offer clues for enhancing interferon effectiveness in cancer treatment.
Accumulated DNA damage linked to neurodegeneration in a rare pediatric disorder

10/15/2021

St. Jude Children’s Research Hospital scientists have identified the disease process that underlies Aicardi-Goutières syndrome, a debilitating illness with no known cure.
DNA damage causes neurological syndrome

10/15/2021

St. Jude scientists found that a DNA repair system breakdown is to blame for Aicardi-Goutières syndrome (AGS).
Genetic rescue, a ‘natural gene therapy,’ suggests possible new approach to pediatric MDS

10/07/2021

St. Jude and the European Working Group of MDS in Childhood report results of a landmark study of the blood disorders known as pediatric myelodysplastic syndromes.
Learning from ‘natural gene therapy’

10/07/2021

St. Jude scientists worked with researchers in Europe to learn how they might be able to manipulate SAMD9 and SAMD9L genes to the advantage of the patients.
David Rogers honored by American College of Clinical Pharmacy

10/04/2021

The chair of St. Jude Pharmacy/Pharmaceutical Sciences will receive 2 top science honors from ACCP at its annual meeting. It is highly unusual for both to be presented to the same person in the same year.
St. Jude names Shannon Dean, M.D., as chief medical information officer

09/22/2021

Shannon Dean to help oversee launch of hospital’s new electronic health record as the hospital enhances the patient experience.